Effect of chronic and acute thyroid hormone reduction on perioperative outcome

Anesthesia and Analgesia

Volumn 85, Issue 1, 1997, Pages 30-36

  Bennett Guerrero, Elliott ^a   Kramer, David C ^b   Schwinn, Debra A ^b  

^a MOUNT SINAI MEDICAL CENTER   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

THYROID HORMONE;

HORMONAL THERAPY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOTHYROIDISM; INOTROPISM; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; REVIEW; SURGICAL RISK; SURGICAL STRESS; THYROID HORMONE RELEASE; TREATMENT OUTCOME;

ANIMALS; BRAIN DEATH; CARDIOTONIC AGENTS; HEMODYNAMIC PROCESSES; HUMANS; HYPOTHYROIDISM; POSTOPERATIVE COMPLICATIONS; SURGICAL PROCEDURES, OPERATIVE; THYROID HORMONES; TISSUE DONORS; TRIIODOTHYRONINE;

EID: 0030857837     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000539-199707000-00006     Document Type: Review

References (68)

1. Sypniewski E. Comparative pharmacology of the thyroid hormones. Ann Thorac Surg 1993;56:S2-6.
2. Chopra IJ. Nature, source, and relative biologic significance of circulating thyroid hormone. In: Baverman LE, Utiger RD, eds. The thyroid. 6th ed. Philadelphia: JP Lippincott, 1991:126-43.
3. Chopra IJ, Hershman JM, Pardridge WM, Nicoloff JT. Thyroid function in nonthyroidal illnesses. Ann Intern Med 1893;98: 946-57.
4. Larsen PR, Ingbar SH. The thyroid gland. In: Foster DW, Wilson JD, eds, William's textbook of endocrinology. 8th ed. Philadelphia: WB Saunders, 1992;360-487.
5. Saito I, Ito K, Saruta T. Hypothyroidism as a cause of hypertension. Hypertension 1983;5:112-5.
6. Dilmann WH. The cardiovascular system in hypothyroidism. In: Baverman LE and Utiger RD eds. The thyroid. 6th ed. Philadelphia: JP Lippincott, 1991:1002-8.
7. Vora J, O'Malley BP, Petersen S, et al. Reversible abnormalities of myocardial relaxation in hypothyroidism. J Clin Endocrinol Metab 1985;61:269-72.
8. Shenoy MM, Goldman JM. Hypothyroid cardiomyopathy: echocardiographic documentation of reversibility. Am J Med Sci 1987;194:1-9.
9. Singh PI, Sood S, Sood AK. Left ventricular diastolic function in hyperthyroid and hypothyroid states. J Assoc Phys India 1986; 34:845-7.
10. Steinberg AD. Myxedema and coronary artery disease - a comparative autopsy study. Ann Intern Med 1968;68:338-44.
11. Fredlund BO, Olsson SB. Long QT interval and ventricular tachycardia of "torsade de pointe" type in hypothyroidism. Acta Med Scand 1983;213:231-5.
12. Lee JK, Lewis JA. Myxedema with complete A-V block and adam-stokes disease abolished with thyroid medication. Br Heart J 1962;24:253-6.
13. Aber CP, Thompson GS. The heart in hypothyroidism. Am Heart J 1964;68:428-30.
14. Dulchavsky SA, Bailey MS. Triiodothyronine treatment maintains surfactant during sepsis. Surgery 1992;112:475-9.
15. Lindenberg JA, Brehier A, Ballard PL. Triiodothyronine nuclear binding in fetal and adult rabbit lung and cultured lung cells. Endocrinology 1978;103:1725-31.
16. Zwillich CW, Pierson DJ, Hofeldt FD, et al. Ventilatory control in myxedema and hypothyroidism. N Engl J Med 1975;292: 662-5.
17. Ingbar SH, Woebar KA. The thyroid gland. In: Williams RH, ed. Textbook of endocrinology. Philadelphia: WB Saunders, 1981: 117-247.
18. Kim JM, Hackman L. Anesthesia for untreated hypothyroidism: report of three cases. Anesth Analg 1977;56:299-302.
19. Lamberg BA, Gordin A. Abnormalities of thyrotropin secretion and clinical implications of the thyrotropin releasing hormone stimulation test. Ann Clin Res 1978;10:171-83.
20. Abbott TR. Anesthesia in untreated myxedema: report of two cases. Br J Anaesth 1967;39:510-4.
21. 2 retention. Acta Med Scand 1960;166:189-94.
22. White VA, Kumagai LF. Preoperative endocrine and metabolic considerations. Med Clin North Am 1979;63:1321-34.
23. Smith SE. Sedative and hypnotic drugs and intravenous agents. In: Churchill-Davidson HC, ed. A practice of anesthesia. Toronto: WB Saunders, 1978:746-84.
24. Pender JW, Fox M, Basso LV. Diseases of the endocrine system. In: Katz J, Benumof J, Kadis LB, eds. Anesthesia and uncommon diseases. Philadelphia: WB Saunders, 1981:155-220.
25. Munson ES, Hoffman JC, DiFazio CA. The effects of acute hypothyroidism and hyperthyroidism on cyclopropane requirement (MAC) in rats. Anesthesiology 1968;29:1094-8.
26. Badad AA, Eger EI II. The effects of hyperthyroidism and hypothyroidism on halothane and oxygen requirements in dogs. Anesthesiology 1968;29:1087-93.
27. Anderson A, Hausmann W. Triiodothyronine in myxoedema coma [letter]. Lancet 1956;2:999.
28. Keating FR, Parkin TW, Shelby JB. Treatment of heart disease associated with myxedema. Prog Cardiovasc Dis 1960;3:364-81.
29. Dyke CM, Yeh T Jr., Lehman JD, et al. Triiodothyronine-enhanced left ventricular function after ischemic injury. Ann Thorac Surg 1991;52:14-9.
30. Karlsberg RP, Friscia DA, Aronow WS, Sekhon SS. Deleterious influence of hypothyroidism on evolving myocardial infarction in conscious dogs. J Clin Invest 1981;67:1024-34.
31. Breisblatt WM, Stein KL, Wolfe CJ, et al. Acute myocardial dysfunction and recovery: a common occurrence after coronary bypass surgery. J Am Coll Cardiol 1990;15:1261-9.
32. Mangano DT. Biventricular function after myocardial revascularization in humans: deterioration and recovery patterns during the first 24 hours. Anesthesiology 1985;62:571-7.
33. Bremmer WF, Taylor KM, Baird S, et al. Hypothalamo-pituitary-thyroid axis function during cardiopulmonary bypass. J Thorac Cardiovasc Surg 1978;75:392-9.
34. 3 syndrome" with blunted thyrotropin (TSH) response to thyrotropin-releasing hormone (TRH). Hormone Res 1986;23:151-8.
35. Holland FWW, Brown PS, Weintraub BD, Clark RE. Cardiopulmonary bypass and thyroid function: a "euthyroid sick syndrome." Ann Thorac Surg 1991;52:46-50.
36. Chu SH, Huang TS, Hsu RB, et al. Thyroid hormone changes after cardiovascular surgery and clinical implications. Ann Thorac Surg 1991;52:791-6.
37. Mitchell IM, Pollock JCS, Jamieson MPG, et al. The effects of cardiopulmonary bypass on thyroid function in infants weighing less than five kilograms. J Thorac Cardiovasc Surg 1992;103: 800-5.
38. Goetzsche BH, Weeke J. Changes in plasma free thyroid hormones during cardiopulmonary bypass do not indicate triiodothyronine substitution. J Thorac Cardiovasc Surg 1992;104: 273-7.
39. Novitzky D, Cooper DKC, Swanepoel A. Inotropic effect of triiodothyronine (T3) in low cardiac output following cardioplegic arrest and cardiopulmonary bypass: an initial experience in patients undergoing open heart surgery. Eur J Cardiothorac Surg 1989;3:140-5.
40. Teiger E, Menasche P, Mansier P, et al. Triiodothyronine therapy in open-heart surgery: from hope to disappointment. Eur Heart J 1993;14:629-33.
41. Salati M, Scrofani R, Santoli C. Changes in triiodothyronine during cardiopulmonary bypass: a clinical problem? J Thorac Cardiovasc Surg 1990;100:464-5.
42. Novitzky D, Cooper DKC, Barton CI, et al. Triiodothyronine as an inotropic agent after open heart surgery. J Thorac Cardiovasc Surg 1989;98:972-8.
43. Klemperer JD, Klein I, Gomez M, et al. Thyroid hormone treatment after coronary-artery bypass surgery. N Engl J Med 1995; 333:1522-7.
44. Bennett-Guerrero E, Jimenez JL, White WD, et al. Cardiovascular effects of intravenous triiodothyronine in patients undergoing coronary artery bypass graft surgery: a randomized, double-blind, placebo-controlled trial. JAMA 1996;275:687-92.
45. Palazzo MG, Suter PM. Delivery dependent oxygen consumption in patients with septic shock: daily variations, relationship with outcome and the sick-euthyroid. Intensive Care Med 1991; 17:325-32.
46. LoPresti JSS, Fried JC, Spencer CA, Nicoloff JT. Unique alterations of thyroid hormone indices in the acquired immunodeficiency syndrome (AIDS). Ann Intern Med 1989;110:970-5.
47. Hamblin PS, Dyer SA, Mohr VS, et al. Relationship between thyrotropin and thyroxine changes during recovery from severe hypothyroxinemia of critical illness. J Clin Endocrinol Metab 1986;62:717-22.
48. Kaptein EM, Weiner JM, Robinson WJ, et al. Relationship of altered thyroid hormone indices to survival in nonthyroidal illnesses. Clin Endocrinol 1982;16:565-74.
49. Chiolero RL, Lemarchand-Beraud T, Schutz Y, et al. Thyroid function in severely traumatized patients with or without head injury. Acta Endocrinool (Copenh) 1988;117:80-6.
50. Slag MF, Morley JE, Elson MK, et al. Hypothroxinemia in critically ill patients as a predictor of high mortality. J Am Med Assoc 1981;245:43-5.
51. Hamilton MA, Stevenson LW, Luu M, Walden JA. Altered thyroid hormone metabolism in advanced heart failure. J Am Coll Cardiol 1990;16:91-5.
52. Snow TR, Deal MT, Connelly TS, et al. Acute inotropic response of rabbit papillary muscle to triiodothyronine. Cardiology 1992; 80:112-7.
53. Holland FW II, Brown PS Jr, Clark RE. Acute severe postischemic myocardial depression reversed by triiodothyronine. Ann Thorac Surg 1992;54:301-5.
54. Wechsler AS, Kadletz M, Ding M, et al. Effects of triiodothyronine on stunned myocardium. J Cardiovasc Surg 1993;8:338-41.
55. Novitzky D, Human PA, Cooper DKC. Inotropic effect of triiodothyronine following myocardial ischemia and cardiopulmonary bypass: an experimental study in pigs. Ann Thorac Surg 1988;45:50-5.
56. Novitzky D, Matthews N, Shawley D, et al. Triiodothyronine in the recovery of stunned myocardium in dogs. Ann Thorac Surg 1991;51:10-7.
57. Rorie DG, Butterworth JF, Royster RI, et al. Triiodothyronine increases contractility independent of β-adrenergic receptors or stimulation of cyclic-3′, 5′-adenosine monophosphate. Anesthesiology, 1995;82:1004-12.
58. Klemperer JD, Zelano J, Helm RE, et al. Triiodothyronine improves left ventricular function without oxygen wasting effects after global hypothermic ischemia. J Thorac Cardiovasc Surg 1995;109:457-65.
59. Segal J. Action of the thyroid hormone at the level of the plasma membrane. Endocr Res 1989;15:619-49.
60. 3): effects on myocyte contractile function after hypothermic cardioplegic arrest and rewarming. J Thorac Cardiovasc Surg 1995;110:315-27.
61. Sterling K. Direct thyroid hormone activation of mitochondria: the role of adenine nucleotide translocase. Endocrinology 1986; 119:292-5.
62. Novitzky D, Wicomb WN, Cooper DKC, et al. Electrocardiographic, hemodynamic, and endocrine changes during experimental brain death in the chacma baboon. J Heart Transplant 1984;4:63-9.
63. Novitzky D, Cooper DK, Wicomb WN, Reichart B. Hemodynamic changes, myocardial injury, and pulmonary edema induced by sympathetic activity during the development of brain death in the baboon. Transplant Proc 1986;18:609-12.
64. Novitzky D, Wicomb WN, Cooper DKC, et al. Prevention of myocardial injury during brain death by total cardiac sympathectomy in the Chacma baboon. Ann Thorac Surg 1986;41: 520-4.
65. Novitzky D, Wicomb WN, Cooper DKC, et al. Improved cardiac function following hormonal therapy in brain dead pigs: relevance to organ donation. Heart Transplant Cryobiol 1987;24: 1-4.
66. Novitzky D, Cooper DKC, Morrell D, Isaacs S. Change from aerobic to anaerobic metabolism after brain death, and reversal following triiodothyronine therapy. Transplantation 1988;45: 32-6.
67. Novitzky D, Cooper DKC, Reichart B. Hemodynamic and metabolic responses to hormonal therapy in brain-dead potential organ donors. Transplantation 1987;43:852-4.
68. Novitzky D, Cooper DK, Chaffin JS, et al. Improved cardiac allograft function following triiodothyronine therapy to both donor and recipient. Transplantation 1990;49:311-6.